This article was originally published in The Rose Sheet
Executive SummaryCosmetics division third quarter sales benefit from diversification of Clarins brand with Clarins Men skin care debut and U.S. launch of Hugo Boss Boss In Motion men's fragrance, Parisian firm reports in 1third quarter sales release Oct. 18. Consolidated sales for the quarter were up 3.4% to $204.7 mil. For the nine months, Clarins brand sales rose 1.4% to $388.6. (€1=$.97) at average exchange rates, and Thierry Mugler grew 7.1% to $115.7 mil. Azzaro sales increased 3.1% to $66.1mil., and Perfume Distribution sales were $63.4 mil., up 5.8%...
You may also be interested in...
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV therapy or prevention with broadly neutralizing antibodies discovered by Rockefeller U.